Drug
Vilanterol clinical trials
Also written GW642444.
- studies test it
- 73
- open now
- 5
- in phase 3
- 30
- first study started
- 2005
Keep track of what changes. Save the vilanterol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
73 studies that test it; most in 2011 (9)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 13
- Phase 2
- 11
- Phase 3
- 30
- Phase 4
- 16
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
- Asthma
- 16
Who runs them
Industry 61 · Other 12
GlaxoSmithKline (59) · Novartis Pharmaceuticals (2) · Morten Hostrup, PhD (2) · Samsung Medical Center (1) · Dr. Grace Parraga (1) · Luis Puente Maestu (1) · Thammasat University (1) · Rambam Health Care Campus (1)
Often tested with
Tested in the same studies.
Fluticasone furoate (40) · GSK573719 (25) · Tiotropium (3) · Darotropium bromide (3) · Umeclidinium bromide (2) · Glycopyrrolate (2) · Indacaterol-glycopyrronium combination (2) · Indacaterol (2)
Studies
Open first, then newest update. How each study uses vilanterol is read from its arms, and is right about nine times in ten.
Testing it · 73
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruitingPhase 3GlaxoSmithKlineNCT05757102Written as FF/UMEC/VI
- 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationRecruitingPhase 4Western University, CanadaNCT07192016Written as fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg
- U-LABA/ICS Effects on Exercise Performance, VilanterolRecruitingNot applicableMorten Hostrup, PhDNCT06066606Written as Vilanterol and Fluticasone Furoate (low dose)
- Role of Lung Function for Exercise Capacity in Well-trained IndividualsRecruitingNot applicableMorten Hostrup, PhDNCT06077019Written as Vilanterol and Fluticasone Furoate
- Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass ExposureRecruitingPhase 4National Institute of Respiratory Diseases, MexicoNCT06571942Written as Vilanterol / Umeclidinium (25/62.5 mcg)
- Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNot applicableMedical University of BialystokNCT07541378Written as Vilanterol
- Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart FailureCompletedPhase 4Luis Puente MaestuNCT04522596Written as Umeclidinium/vilanterol
- Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer SurgeryActive, not recruitingPhase 3Samsung Medical CenterNCT04536675Written as Vilanterol and Umeclidinium Bromide
- Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedPhase 4Thammasat UniversityNCT06905483Written as Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)
- To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPDCompletedPhase 4GlaxoSmithKlineNCT05535972Written as FF/UMEC/VI
- Evaluation of Triple Therapy Using Magnetic Resonance Imaging in AsthmaActive, not recruitingPhase 3Dr. Grace ParragaNCT04651777Written as FF/UMEC/VI
- Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled AsthmaCompletedPhase 3GlaxoSmithKlineNCT04937387Written as FF/VI
- A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT04923347Written as FF/UMEC/VI
- A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03474081Written as FF/UMEC/VI
- Effect of Fluticasone Furoate/Vilanterol on EIA in AdolescentsCompletedPhase 4Rambam Health Care CampusNCT04750603Written as Fluticasone furoate (FF)/Vilanterol (VI)
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478696Written as FF/UMEC/VI
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478683Written as FF/UMEC/VI
- INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignCompletedPhase 4GlaxoSmithKlineNCT03467425Written as FF/UMEC/VI
- Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPDCompletedPhase 2GlaxoSmithKlineNCT00749411Written as GSK233705/GW642444
- INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and OlodaterolCompletedPhase 4University of DundeeNCT03152149Written as fluticasone furoate & vilanterol
See all 73 studies that test vilanterol →
Given in every arm · 1 — vilanterol is usual care beside what is tested
As the comparator · 2 — what is tested is compared with vilanterol
- Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedPhase 3AstraZenecaNCT03162055Written as umeclidinium/vilanterol
- Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With AsthmaCompletedPhase 2GlaxoSmithKlineNCT01573624Written as FF/VI
Codes
What other systems call vilanterol · ClinicalTrials.gg INT005657
- MeSH (NLM) C550468vilanterolOne source NLM
- UNII (FDA) 028LZY775BVILANTEROLConfirmed FDA, NLM, Wikidata
- RxNorm 1424884Confirmed FDA, Wikidata
- Wikidata Q15053666vilanterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152875VilanterolOne source FDA
- DrugBank DB09082One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C550468 | vilanterol | One source NLM |
| UNII (FDA) | 028LZY775B | VILANTEROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1424884 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15053666 | vilanterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152875 | Vilanterol | One source FDA |
| DrugBank | DB09082 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.